Latest News
Peter Na, MD, MPH, assistant professor of psychiatry, spoke to TIME for an article about the high rates of suicide in South Korea.
- June 12, 2024
VA Connecticut Healthcare Center and Yale School of Medicine researchers have completed the first well-powered, genome-wide association study of epiretinal membrane, a common retinal disorder that often causes visual distortion or loss of visual acuity. The first author was Joel Gelernter, MD. Co-author was Daniel Levey, PhD.
- April 05, 2024Source: Molecular Psychiatry
Marco Galimberti, PhD, postdoctoral associate, and Joel Gelernter, MD, Foundations Fund Professor of Psychiatry and Professor of Genetics and of Neuroscience, are first and senior authors, respectively, of a paper on Molecular Psychiatry that investigates the genetic architecture and causal relationships between cannabis use disorder and lifetime cannabis use with risk for developing substance use disorders and substance use traits.
- February 06, 2024
A new study by VA Connecticut Healthcare System and Yale School of Medicine researchers assesses how the most up-to-date genetic and psychosocial predictors of opioid use disorder compare and combine when predicting the risk of becoming dependent on opioids.
- December 07, 2023
A study led by VA Connecticut Healthcare Center/Yale researchers reveals ancestries around the world possess a shared genetic architecture for problematic alcohol use – habitual heavy drinking, accompanied by harmful consequences. Hang Zhou, PhD, assistant professor of psychiatry and of biomedical informatics & data science at Yale School of Medicine and VA Connecticut, and Joel Gelernter, MD, Foundations Fund Professor of Psychiatry, and professor of genetics and of neuroscience at Yale School of Medicine and VA Connecticut, were first and senior authors, respectively.
- December 07, 2023
A new study led by the National Center for PTSD and Yale researchers analyzed data from a nationally representative sample of more than 2,400 U.S. veterans to examine subjective ratings and key sociodemographic, health, and psychosocial correlates of well-being. Peter Jongho Na, MD, MPH, and Robert Pietrzak, PhD, MPH, were lead and senior authors of the study, published in JAMA Network Open.
- November 20, 2023Source: YaleNews
A Yale-led analysis of the genomes of more than 1 million people has shed light on the underlying biology of cannabis use disorder and associated risks.
- November 20, 2023
In a landmark research study, scientists have unveiled the results of a comprehensive genome-wide association study (GWAS), published in Nature Genetics, shedding new light on the genetic factors underlying cannabis use disorders (CanUD) and their potential link to lung cancer.
- September 29, 2023
Joel Gelernter, MD, Foundations Fund Professor of Psychiatry and Professor of Genetics and of Neuroscience, and Marc Potenza, MD, PhD, Albert E. Kent Professor of Psychiatry and Professor in the Child Study Center and of Neuroscience have received a federal grant to study and identify genetic risk variants for methamphetamine use disorder and related mental health traits in people in Thailand.